Nam Q. Bui
Impact in
-
- Sarcoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Oncology top 10%
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Sarcoma Diagnosis and Treatment 38
- Lung Cancer Treatments and Mutations 8
- Brain Metastases and Treatment 5
- Oncology 38
- Vascular Tumors and Angiosarcomas 15
- CAR-T cell therapy research 5
- Co-authors
- Kristen N. GanjooRazelle KurzrockBrian WoodwardHatim HusainGregory W. CharvilleShivaani KummarMatt van de RijnDavid S. Wang
- Journals
- Journal of Clinical Oncology (17 papers)Cancers (8 papers)Annals of Oncology (5 papers)Clinical Cancer Research (4 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Nam Q. Bui
74 papers receiving 755 citations
Peers
Comparison fields: 5 of 99
- Pulmonary and Respiratory Medicine 374
- Oncology 307
- Cancer Research 166
- Rheumatology 85
- Pathology and Forensic Medicine 97
Countries citing papers authored by Nam Q. Bui
This map shows the geographic impact of Nam Q. Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nam Q. Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nam Q. Bui more than expected).
Fields of papers citing papers by Nam Q. Bui
This network shows the impact of papers produced by Nam Q. Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nam Q. Bui. The network helps show where Nam Q. Bui may publish in the future.
Co-authors
The 25 scholars most cited alongside Nam Q. Bui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 14 | |
| 14 | 2022 | 16 | |
| 15 | 2022 | 3 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 0 | |
| 18 | 2019 | 34 | |
| 19 | 2018 | 50 | |
| 20 | 2017 | 76 |
About Nam Q. Bui
Nam Q. Bui is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Rheumatology and Pathology and Forensic Medicine, having authored 80 papers that have together received 766 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (38 papers), Vascular Tumors and Angiosarcomas (15 papers), Cancer Genomics and Diagnostics (11 papers), Cardiac tumors and thrombi (9 papers), Lung Cancer Treatments and Mutations (8 papers), Brain Metastases and Treatment (5 papers), Soft tissue tumor case studies (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (374 citations), Oncology (307 citations), Cancer Research (166 citations), Rheumatology (85 citations) and Pathology and Forensic Medicine (97 citations). Nam Q. Bui has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Kristen N. Ganjoo, Razelle Kurzrock, Brian Woodward, Hatim Husain, Gregory W. Charville, Shivaani Kummar, Matt van de Rijn, David S. Wang, Joanna Przybył and Radha Duttagupta. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Annals of Oncology, Clinical Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.